title: Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
authors.forename: Jan
authors.initials: J
authors.lastname: Novy
authors.forename: Anne
authors.initials: A
authors.lastname: Rosselet
authors.forename: Olivier
authors.initials: O
authors.lastname: Spertini
authors.forename: Johannes Alexander
authors.initials: JA
authors.lastname: Lobrinus
authors.forename: Thomas
authors.initials: T
authors.lastname: Pabst
authors.forename: Thierry
authors.initials: T
authors.lastname: Kuntzer
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D017696:Myopathies, Nemaline / Q000188:drug therapy*; D010265:Paraproteinemias / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan